176 related articles for article (PubMed ID: 8186114)
1. Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp.
Green C; Ganpule M; Harris D; Kavanagh G; Kennedy C; Mallett R; Rustin M; Downes N
Br J Dermatol; 1994 Apr; 130(4):483-7. PubMed ID: 8186114
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis.
Klaber MR; Hutchinson PE; Pedvis-Leftick A; Kragballe K; Reunala TL; Van de Kerkhof PC; Johnsson MK; Molin L; Corbett MS; Downess N
Br J Dermatol; 1994 Nov; 131(5):678-83. PubMed ID: 7999600
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
4. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
[TBL] [Abstract][Full Text] [Related]
5. Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial.
Liu L; Zhang C; Wang J; Chen K; Ding Y; Yan G; Lu Q; Li W; Fang H; Cheng H; Zhang J; He Y; Zhu W; Lu Y; Huang J; Pan W; Li M; Cao S; Li S; Han X; He L; Chen Y; Zheng M
Eur J Dermatol; 2020 Oct; 30(5):580-590. PubMed ID: 33052103
[TBL] [Abstract][Full Text] [Related]
6. Calcipotriol solution in scalp psoriasis.
Duweb G; Alhaddar J; Abuhamida M
Int J Tissue React; 2005; 27(4):163-6. PubMed ID: 16440580
[TBL] [Abstract][Full Text] [Related]
7. Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients.
Thaçi D; Daiber W; Boehncke WH; Kaufmann R
Dermatology; 2001; 203(2):153-6. PubMed ID: 11586015
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients.
Andreassi L; Giannetti A; Milani M;
Br J Dermatol; 2003 Jan; 148(1):134-8. PubMed ID: 12534607
[TBL] [Abstract][Full Text] [Related]
9. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis.
van de Kerkhof PC; Cambazard F; Hutchinson PE; Haneke E; Wong E; Souteyrand P; Damstra RJ; Combemale P; Neumann MH; Chalmers RJ; Olsen L; Revuz J
Br J Dermatol; 1998 Jan; 138(1):84-9. PubMed ID: 9536227
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
[TBL] [Abstract][Full Text] [Related]
11. The hair root pattern after calcipotriol treatment for scalp psoriasis.
Kuijpers AL; van Baar HM; van Gasselt MW; van de Kerkhof PC
Acta Derm Venereol; 1995 Sep; 75(5):388-90. PubMed ID: 8615060
[TBL] [Abstract][Full Text] [Related]
12. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
13. Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
Ma L; Yang Q; Yang H; Wang G; Zheng M; Hao F; Gu J; Sun Q; Cui P; Ge M; Li R; Gao T; Facy P; Kurvits M; Xu Z; Xu J
Int J Dermatol; 2016 Jan; 55(1):106-13. PubMed ID: 26094549
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
Feldman SR; Mills M; Brundage T; Eastman WJ
J Drugs Dermatol; 2013 Mar; 12(3):300-6. PubMed ID: 23545912
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
Molin L; Cutler TP; Helander I; Nyfors B; Downes N
Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
[TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
[TBL] [Abstract][Full Text] [Related]
17. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
Ruzicka T; Trompke C
Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study.
Dubertret L; Wallach D; Souteyrand P; Perussel M; Kalis B; Meynadier J; Chevrant-Breton J; Beylot C; Bazex JA; Jurgensen HJ
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):983-8. PubMed ID: 1479106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]